Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection

Rohan Merani, Mark W. Johnson, Colin A. McCannel, Harry W. Flynn, Ingrid U. Scott, Alex P. Hunyor

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.

Original languageEnglish (US)
Pages (from-to)443-451
Number of pages9
JournalJournal of VitreoRetinal Diseases
Volume6
Issue number6
DOIs
StatePublished - Nov 1 2022

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection'. Together they form a unique fingerprint.

Cite this